After the relaxation of epidemic control measures in China, some cities have driven up the prices of some epidemic-related materials such as Lianhua to clear plague and antigen detection reagents. The Guangzhou Municipal Market Supervision Department notified four typical cases and severely cracked down on price violations such as driving up the prices of drugs and epidemic prevention products, and hoarding.

According to the "Guangzhou Market Supervision" WeChat official account on Wednesday (December 14), the market supervision department carried out a special project to check the price of drugs and epidemic prevention products and announced four typical cases, among which a pharmaceutical company greatly increased the "Lianhua Qingpest" The wholesale supply price of medicines has risen to 6.5 times the original price difference, and the purchase price difference rate of antigen detection reagents has exceeded 230%.

In the first typical case, a Guangdong Pharmaceutical Co., Ltd., as a wholesale supplier of "Lianhua Clear Plague" drugs, greatly increased the wholesale supply price of drugs when the purchase price of drugs did not increase significantly, and the price difference between purchase and sales rose to a maximum of 6.5 times of the original., which will further lead to excessive and rapid increases in the price of drugs at the end point of sales.

In the second typical case, a pharmacy in Zengcheng District, Guangzhou greatly increased the sales price of drugs without any change in the purchase price, which was suspected of constituting an illegal act of price gouging. Among them, the sales price of "Lianhua Qingpest Granules" rose from 40 yuan (RMB, the same below, about S $7.75) to 58 yuan a box, and the purchase price difference rate increased by 62%; the sales price of "Lianhua Qingpest Capsules" rose from 48 yuan a box to 80 yuan a box, and the purchase price difference rate increased by 119%.

Typical Case 3 In the case of no or little change in cost, a large pharmacy Co., Ltd. in Guangzhou increased the sales price of a batch of "Lianhua Qingpest Granules" from 43 yuan per box to a maximum of 68 yuan per box. The company significantly increased the sales price of Lianhua Qingpest Capsules, which is suspected of constituting an illegal act of driving up prices.

In the fourth typical case, a large pharmacy in Guangzhou Co., Ltd. sold a coronary antigen detection kit with a purchase price of 3 yuan a piece) to the outside world at a price ranging from 9.9 yuan to 16 yuan, with a purchase price difference of more than 230%. The purchase price difference rate of the store's congeneric products in March 2022 was only 65%, and the selling price also greatly exceeded the average sales price of congeneric products in Guangzhou. The store greatly increased the purchase price difference rate of antigen detection reagents during the adjustment and optimization of epidemic measures, which promoted the market price to rise, and was suspected of constituting an illegal act of price gouging.

The operators in the above four typical cases were all investigated by the local market supervision department.

Guangzhou Market Supervision and Administration Bureau reminds relevant operators in the fields of production and circulation to take a lesson from it, conduct self-examination and rectification of their own price behavior, operate in good faith and compliance, and jointly maintain a good and stable price order in the city.